![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SBSN mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SBSN mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1562305 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SBSN mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SBSN mRNA | CTD | PMID:21570461 | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of SBSN mRNA | CTD | PMID:30951980 | acetylsalicylic acid | multiple interactions | ISO | RGD:1602809 | 6480464 | Aspirin inhibits the reaction [thrombin receptor-activating peptide SFLLRNPNDKY analog results in increased secretion of SBSN protein] | CTD | PMID:17303692 | aflatoxin B1 | increases methylation | ISO | RGD:1602809 | 6480464 | Aflatoxin B1 results in increased methylation of SBSN exon | CTD | PMID:30157460 | aristolochic acid A | increases expression | ISO | RGD:1602809 | 6480464 | aristolochic acid I results in increased expression of SBSN mRNA | CTD | PMID:33212167 | arsane | multiple interactions | ISO | RGD:1602809 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SBSN mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | RGD:1602809 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SBSN mRNA | CTD | PMID:32525701 | arsenous acid | multiple interactions | ISO | RGD:1602809 | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SBSN protein] | CTD | PMID:26598702 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of SBSN mRNA | CTD | PMID:19770486 | bisphenol A | affects expression | ISO | RGD:1562305 | 6480464 | bisphenol A affects the expression of SBSN mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SBSN mRNA | CTD | PMID:34585602 | bisphenol A | increases expression | ISO | RGD:1562305 | 6480464 | bisphenol A results in increased expression of SBSN mRNA | CTD | PMID:30816183 more ... | bisphenol A | increases expression | ISO | RGD:1602809 | 6480464 | bisphenol A results in increased expression of SBSN mRNA | CTD | PMID:27685785 | butanal | increases expression | ISO | RGD:1602809 | 6480464 | butyraldehyde results in increased expression of SBSN mRNA | CTD | PMID:25014914, PMID:26079696 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SBSN mRNA | CTD | PMID:20938992 | chrysene | increases expression | EXP | | 6480464 | chrysene results in increased expression of SBSN mRNA | CTD | PMID:26377693 | cisplatin | multiple interactions | ISO | RGD:1602809 | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of SBSN mRNA | CTD | PMID:27392435 | cisplatin | decreases expression | ISO | RGD:1602809 | 6480464 | Cisplatin results in decreased expression of SBSN mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | RGD:1562305 | 6480464 | cobaltous chloride results in decreased expression of SBSN mRNA | CTD | PMID:24386269 | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of SBSN mRNA | CTD | PMID:18355967 | cocaine | multiple interactions | EXP | | 6480464 | FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of SBSN mRNA] | CTD | PMID:18355967 | crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of SBSN mRNA | CTD | PMID:23917077 | cyclosporin A | decreases methylation | ISO | RGD:1602809 | 6480464 | Cyclosporine results in decreased methylation of SBSN promoter | CTD | PMID:27989131 | D-mannitol | decreases expression | EXP | | 6480464 | Mannitol results in decreased expression of SBSN mRNA | CTD | PMID:25270620 | dexamethasone | increases expression | ISO | RGD:1602809 | 6480464 | Dexamethasone results in increased expression of SBSN mRNA | CTD | PMID:25047013 | diarsenic trioxide | multiple interactions | ISO | RGD:1602809 | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SBSN protein] | CTD | PMID:26598702 | diuron | decreases expression | ISO | RGD:1562305 | 6480464 | Diuron results in decreased expression of SBSN mRNA | CTD | PMID:21551480, PMID:25152437 | folic acid | multiple interactions | EXP | | 6480464 | [1 more ... | CTD | PMID:20938992, PMID:22206623 | fonofos | increases methylation | ISO | RGD:1602809 | 6480464 | Fonofos results in increased methylation of SBSN promoter | CTD | PMID:22847954 | gentamycin | increases expression | ISO | RGD:1562305 | 6480464 | Gentamicins results in increased expression of SBSN mRNA | CTD | PMID:33387578 | heptanal | increases expression | ISO | RGD:1602809 | 6480464 | heptanal results in increased expression of SBSN mRNA | CTD | PMID:25014914 | hexadecanoic acid | increases expression | ISO | RGD:1602809 | 6480464 | Palmitic Acid results in increased expression of SBSN mRNA | CTD | PMID:32347412 | Indeno[1,2,3-cd]pyrene | decreases expression | EXP | | 6480464 | indeno(1 more ... | CTD | PMID:26377693 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SBSN mRNA | CTD | PMID:20938992 | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of SBSN mRNA | CTD | PMID:21829687 | Licochalcone B | increases expression | ISO | RGD:1602809 | 6480464 | licochalcone B results in increased expression of SBSN mRNA | CTD | PMID:33647349 | lipopolysaccharide | multiple interactions | ISO | RGD:1602809 | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | RGD:1602809 | 6480464 | Lipopolysaccharides results in increased expression of SBSN mRNA | CTD | PMID:35811015 | methylmercury chloride | increases expression | ISO | RGD:1562305 | 6480464 | methylmercuric chloride results in increased expression of SBSN mRNA | CTD | PMID:31378766 | nitrofen | increases expression | ISO | RGD:1562305 | 6480464 | nitrofen results in increased expression of SBSN mRNA | CTD | PMID:33484710 | octanal | increases expression | ISO | RGD:1602809 | 6480464 | caprylic aldehyde results in increased expression of SBSN mRNA | CTD | PMID:25014914 | paracetamol | decreases expression | ISO | RGD:1562305 | 6480464 | Acetaminophen results in decreased expression of SBSN mRNA | CTD | PMID:33387578 | paraquat | increases expression | ISO | RGD:1562305 | 6480464 | Paraquat results in increased expression of SBSN mRNA | CTD | PMID:32680482 | parathion | increases methylation | ISO | RGD:1602809 | 6480464 | Parathion results in increased methylation of SBSN promoter | CTD | PMID:22847954 | pentanal | increases expression | ISO | RGD:1602809 | 6480464 | pentanal results in increased expression of SBSN mRNA | CTD | PMID:25014914, PMID:26079696 | propanal | increases expression | ISO | RGD:1602809 | 6480464 | propionaldehyde results in increased expression of SBSN mRNA | CTD | PMID:25014914, PMID:26079696 | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of SBSN mRNA | CTD | PMID:21278054 | resveratrol | multiple interactions | ISO | RGD:1602809 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of SBSN mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:1602809 | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | sodium arsenate | multiple interactions | ISO | RGD:1602809 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SBSN mRNA | CTD | PMID:32525701 | terbufos | increases methylation | ISO | RGD:1602809 | 6480464 | terbufos results in increased methylation of SBSN promoter | CTD | PMID:22847954 | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of SBSN mRNA | CTD | PMID:17484886 | thioacetamide | decreases expression | ISO | RGD:1562305 | 6480464 | Thioacetamide results in decreased expression of SBSN mRNA | CTD | PMID:34492290 | titanium dioxide | affects expression | EXP | | 6480464 | titanium dioxide affects the expression of SBSN mRNA | CTD | PMID:23557971 | toluene | decreases expression | ISO | RGD:1562305 | 6480464 | Toluene results in decreased expression of SBSN mRNA | CTD | PMID:22967744 | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of SBSN mRNA | CTD | PMID:33045310 | valproic acid | increases methylation | ISO | RGD:1602809 | 6480464 | Valproic Acid results in increased methylation of SBSN gene | CTD | PMID:29154799 | versicolorin A | increases expression | ISO | RGD:1602809 | 6480464 | versicolorin A results in increased expression of SBSN mRNA | CTD | PMID:32106047 | |